NASDAQ: RYZB - RayzeBio, Inc. Common Stock

六个月盈利: 0%
股息率: 0.00%
部门: Healthcare

促销时间表 RayzeBio, Inc. Common Stock

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 RayzeBio, Inc. Common Stock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs).

更多详情
It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2023-09-14
ISIN US75525N1072
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://rayzebio.com
Цена ао 62.49
每日价格变化: 0% (62.49)
每周价格变化: 0% (62.49)
每月价格变化: 0% (62.49)
3个月内价格变化: 0% (62.49)
六个月内的价格变化: 0% (62.49)
每年价格变化: 0% (62.49)
年初以来价格变化: 0% (62.49)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % 0 0
ROE, % 0 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 953.57 10
盈利能力 EPS, % 2126.11 10
全部的: 8
更多详情

机构 体积 分享, %
Viking Global Investors, L.P. 6642700 11.09
venBio Partners LLC 5158162 8.61
Versant Venture Management, LLC 5158161 8.61
VR Adviser, LLC 4030471 6.73
Wellington Management Group, LLP 3504409 5.85
Sofinnova Investments, Inc. 2419528 4.04
Orbimed Advisors LLC. 2365213 3.95
Redmile Group, LLC 1857706 3.1
Samsara BioCapital, LLC 1845948 3.08
Blackrock Inc. 1368838 2.28



导师 职称 支付 出生年份
Dr. Kenneth Song M.D. President, CEO & Director 646k 1975 (50 年)
Mr. Arvind Kush Chief Financial Officer 714.76k 1983 (42 年)
Dr. Susan Moran M.D. Chief Medical Officer 559.84k 1969 (56 年)
Mr. Aron Marc Knickerbocker Co-Founder N/A 1969 (56 年)
Mr. Jeff Woodley General Counsel N/A
Mr. Eric Bischoff Senior Vice President of Development & Operations N/A
Dr. Gary G. Li Ph.D. Senior Vice President of Biology & Translational Medicine N/A
Ms. Kimberly Ma M.S. Senior Vice President of Clinical Operations N/A
Dr. Nicholas D. Smith Ph.D. Senior Vice President of Chemistry Innovation N/A
Mr. Abhi Bhat Ph.D. Senior VP of Chemistry & Head of Discovery N/A

地址: United States, San Diego. CA, 5505 Morehouse Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://rayzebio.com